Alentis raises €94.5M Series C round

13 April 2023· Allschwil, Switzerland· health, oncology, biotech, b2b, deep_hardware

The financing supports Phase II and Phase I programs for lead products ALE.F02 and ALE.C04, and the further development of the company's CLDN1 platform including ADCs and bi-specific antibodies.

Investors

LeadJeito Capital

Also participating

BpifranceHigh-Tech GründerfondsSchroders CapitalRA Capital ManagementNovo HoldingsBB Pureos Bioventures

About Alentis

Stage

Series D

Headquarters

Allschwil, Switzerland

Founded

2019

Team Size

51–200

Sectors

healthoncologybiotechb2bdeep_hardware

https://alentis.ch/

Source: https://www.startupticker.ch/en/news/alentis-therapeutics-closes-usd-105-million-series-c-round